Dr. Michael Scott Griswold, MD

Dr. Griswold practices at Aspire Senior Living Moberly in Macon, Missouri.

Dr. Griswold's NPI, 1972575694, was assigned on February 6, 2006. Dr. Griswold graduated from University of Missouri, Columbia School of Medicine in 1995. Dr. Griswold holds Missouri license 108169.

Dr. Griswold's primary practice is Aspire Senior Living Moberly, at 1701 Prospect Dr, Macon, MO 63552 in Macon County. The practice phone is (660) 263-9060.

Dr. Griswold's primary practice is Aspire Senior Living Moberly in Macon, Missouri. Dr. Griswold is also affiliated with University Hospital. The medical group on file is Compassus. Dmand AI also links Dr. Griswold to 3 more hospitals, 4 home health agencies, 2 hospices, 1 group practice or clinic, 1 skilled nursing facility and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Griswold practices, 12 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Griswold's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Griswold is licensed in Missouri.

CMS data shows 2,102 Medicare services from Dr. Griswold across 6 procedure codes in 2024, for 514 Medicare patients. Medicare paid $68,091 for them. Every service was in an office.

CMS counts 514 Medicare patients who saw Dr. Griswold in 2024. The largest group is 65 to 74, with 214 patients. 75% of them have high blood pressure, and 61% have high cholesterol. 7% are also on Medicaid. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Griswold's median patient age at 76, with 52% women.

In 2024, Dr. Griswold wrote 20,272 Medicare Part D claims for 1,233 patients. 88% of them were for generic drugs. CMS names the drug for 19,381 of them, across 201 drugs with 11 or more claims each, at $1,141,642 in total drug cost. In 2023, CMS named 18,370 claims across 194 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Griswold for performance year 2024, reported as part of a group. Dr. Griswold accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Griswold as offering telehealth.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 269 general payments to Dr. Griswold from 30 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 99% of the total. Pfizer Inc. paid the most, $730.

Dr. Griswold graduated from University of Missouri, Columbia School of Medicine in 1995.